| DEXTECH MEDICAL AB (PUBL) |
| Schweden |
| Gesundheit |
| SE0005881489 / A14TTX |
| LQ0 (Frankfurt) |
| FRA:LQ0, ETR:LQ0, LQ0:GR |
| - |
| https://dextechmedical.co.. |
|
DexTech Medical AB is a biotechnology company that focuses on developing innovative pharmaceuticals primarily for the treatment of cancer. The company's significant work is in the field of prostate cancer, providing pioneering therapies aimed at impr..
>Volltext.. |
| 17.28 Mio. EUR |
| 16.16 Mio. EUR |
| - |
| -0.13 Mio. EUR |
| -0.53 Mio. EUR |
| -0.03 EUR |
| - |
| 1.14 Mio. EUR |
| -0.1 Mio. EUR |
| 27.74 |
| - |
| -17.09% |
| - |
| - |
| - |
| - |
| DEXTECH |
| 04.04.26 |
|